SENP3 and neoplasm: The absence of SENP3 expression in DCs abrogates IFN-I responses, and the low frequency of IFN-γ-expressing CD4+ and CD8+ effector T cells in the tumor and draining lymphoid nodes results in poor anti-tumor activity [144].